杉井成志 (Narushi Sugii) - マイポータル

基本情報

ORCID iD: https://orcid.org/0000-0001-7255-9776
J-GLOBAL ID: 202301006066139979
researchmap会員ID: R000059579

論文

Acute cerebral hemorrhage mimicking glioblastoma on intraoperative magnetic resonance imaging: A case report.

Satoshi Miyamoto, Narushi Sugii, Takao Tsurubuchi, Eiichi Ishikawa

Radiology case reports 18(9) 3243-3247 2023年9月
Hemorrhagic Complications After Brain Tumor Biopsy: Risk-Reduction Strategies Based on Safer Biopsy Targets and Techniques.

Narushi Sugii, Masahide Matsuda, Takao Tsurubuchi, Eiichi Ishikawa

World neurosurgery 176 e254-e264 2023年8月
Sclerosing meningioma with a large peritumoral cyst: Case report.

Narushi Sugii, Takao Tsurubuchi, Noriaki Sakamoto, Makoto Shibuya, Eiichi Ishikawa

Radiology case reports 18(7) 2401-2406 2023年7月
Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials.

Shinya Watanabe, Takahiro Nonaka, Makoto Maeda, Narushi Sugii, Koichi Hashimoto, Shingo Takano, Tomoyoshi Koyanagi, Masanobu Yamada, Yoshihiro Arakawa, Eiichi Ishikawa

Therapeutic innovation & regulatory science 57(3) 603-610 2023年5月
High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis.

Masahide Matsuda, Masashi Mizumoto, Hidehiro Kohzuki, Narushi Sugii, Hideyuki Sakurai, Eiichi Ishikawa

Radiation oncology (London, England) 18(1) 38-38 2023年2月23日
Frontal sinus giant osteoma with radiologically unusual component suggesting blood supply: A case report.

Noriyuki Watanabe, Takao Tsurubuchi, Taishi Amano, Narushi Sugii, Noriaki Sakamoto, Masahide Matsuda, Shingo Takano, Eiichi Ishikawa

Radiology case reports 18(2) 567-571 2023年2月
P53-negative status and gross total resection as predictive factors for autologous tumor vaccine treatment in newly diagnosed glioblastoma patients.

Erika Yamada, Eiichi Ishikawa, Tsubasa Miyazaki, Shunichiro Miki, Narushi Sugii, Hidehiro Kohzuki, Takao Tsurubuchi, Noriaki Sakamoto, Shinya Watanabe, Masahide Matsuda

Neuro-oncology advances 5(1) vdad079 2023年
Importance of knowledge and experience in regulatory affairs for promoting pharmaceutical drug and medical device development research: A physician’s point-of-view commentary

Shinya Watanabe, Narushi Sugii, Eiichi Ishikawa

Translational and Regulatory Sciences 4(2) 40-44 2022年8月査読有り
Levetiracetam Versus Levetiracetam Plus Sodium Channel Blockers for Postoperative Epileptic Seizure Prevention in Brain Tumor Patients.

Noriyuki Watanabe, Eiichi Ishikawa, Narushi Sugii, Kazuki Sakakura, Masahide Matsuda, Hidehiro Kohzuki, Takao Tsurubuchi, Yosuke Masuda, Alexander Zaboronok, Hiroyoshi Kino …

Cureus 14(5) e24894 2022年5月
Perioperative Deep Vein Thrombosis and D-dimer Measurement in Patients with Brain Tumor.

Emiko Okamoto, Eiichi Ishikawa, Hiroyoshi Kino, Hidehiro Kohzuki, Narushi Sugii, Hiroyuki Naito, Takuma Hara, Satoshi Homma, Masahide Matsuda, Takao Tsurubuchi …

Neurologia medico-chirurgica 62(4) 186-194 2022年4月15日
Maximum resection and immunotherapy improve glioblastoma patient survival: a retrospective single-institution prognostic analysis.

Eiichi Ishikawa, Narushi Sugii, Masahide Matsuda, Hidehiro Kohzuki, Takao Tsurubuchi, Hiroyoshi Akutsu, Shingo Takano, Masashi Mizumoto, Hideyuki Sakurai, Akira Matsumura

BMC neurology 21(1) 282-282 2021年7月19日
Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.

Narushi Sugii, Masahide Matsuda, Genki Okumura, Akira Shibuya, Eiichi Ishikawa, Yasufumi Kaneda, Akira Matsumura

Cancer science 112(1) 81-90 2021年1月
Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment.

Tsubasa Miyazaki, Eiichi Ishikawa, Narushi Sugii, Masahide Matsuda

Cancers 12(7) 2020年7月19日
Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells.

Tsubasa Miyazaki, Eiichi Ishikawa, Masahide Matsuda, Narushi Sugii, Hedihiro Kohzuki, Hiroyoshi Akutsu, Noriaki Sakamoto, Shingo Takano, Akira Matsumura

Brain tumor pathology 37(2) 41-49 2020年4月
Stroke Mimics and Accuracy of Referrals Made by Emergency Department Doctors in Japan for Patients with Suspected Stroke.

Narushi Sugii, Alexander Zaboronok, Hiroyuki Fujimori, Naoaki Sato, Keishi Fujita, Eiichi Ishikawa, Akira Matsumura

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 28(4) 1078-1084 2019年4月
Vessel mimicry as a target of antiangiogenic therapy for glioblastoma

Shingo Takano, Eiichi Ishikawa, Masahide Matsuda, Narushi Sugii, Takao Tsurubuchi, Noriaki Sakamoto, Hiroyoshi Akutsu, Akira Matsumura

BRAIN PATHOLOGY 29 113-113 2019年2月
Regular medications prescribed to elderly neurosurgical inpatients and the impact of hospitalization on potentially inappropriate medications.

Narushi Sugii, Hiroyuki Fujimori, Naoaki Sato, Akira Matsumura

Journal of rural medicine : JRM 13(2) 97-104 2018年11月
Delayed Brain Edema and Swelling following Craniectomy for Evacuation of an Epidural Abscess that Improved by Cranioplasty: Case Report.

Narushi Sugii, Masahide Matsuda, Tomokazu Sekine, Hideaki Matsumura, Tetsuya Yamamoto, Akira Matsumura

Journal of neurological surgery reports 78(3) e109-e112 2017年7月
Radiation-induced angiosarcoma of the brain.

Sodai Hoshiai, Tomohiko Masumoto, Masahide Matsuda, Narushi Sugii, Noriaki Sakamoto, Manabu Minami

BJR case reports 2(2) 20150374-20150374 2016年

MISC

中枢性神経細胞腫の画像と血管新生

杉井成志, 高野晋吾, 山本哲哉, 阿久津博義, 石川栄一, 松田真秀, 坂本規彰, 野口雅之, 増本智彦, 松村明

Brain Tumor Pathology 31(Suppl.) 100-100 2014年5月

共同研究・競争的資金等の研究課題

難治性脳脊髄腫瘍に対する治療前の代謝分子イメージングによる再発予測

日本学術振興会科学研究費助成事業基盤研究(C) 2024年4月 - 2027年3月

鶴淵隆夫, 杉井成志, 籏野健太郎, 中井啓
悪性神経膠腫における腫瘍浸潤白血球と三次リンパ様構造の解明

日本学術振興会科学研究費助成事業若手研究 2023年4月 - 2027年3月

杉井成志
悪性グリオーマにおける免疫抑制と化学療法抵抗性：腫瘍微小環境でのIL-34の役割

日本学術振興会科学研究費助成事業若手研究 2020年4月 - 2023年3月

杉井成志